SeQuent Scientific (SeQuent), has launched Citramox LA 150 mg/ml Suspension Injection for Cattle and Pigs in 10 European countries, including the key markets of Western Europe. The product has recently received approval through its Spanish subsidiary Laboratorios Karizoo, S.A., and will be the first Long-Acting injectable to be offered by SeQuent in Europe.
This new approval for SeQuent builds on the recent approvals of Tulazzin (Tulathromycin) and Halofusol (Halofuginone) in Europe. All these approvals have been received within 12 months of filing, which reflects on SeQuent’s growing strengths in introducing new products for the regulated markets.
Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.
